Table 1.

lncRNAs as potential biomarker for sepsis and sepsis-induced organ dysfunctions.

lncRNA	Sepsis patients/healthy controls	Diagnosis value of sepsis (AUC)	Prognostic value of mortality (AUC)	sample	level	Ref
lncRNA ZFAS1	202/200	0.814	0.628	plasma	down	(Xu and Shao, 2019)
lncRNA NEAT1	59/56	0.851	-	peripheral blood mononuclear cells	up	(Huang et al., 2017)
lncRNA NEAT1	152/150	0.730	0.641	plasma	up	(Huang et al., 2018)
lncRNA NEAT1/miR-124 axis	82/82	0.829	0.830	plasma	up	(He et al., 2019)
lncRNA MALAT1	120/60	0.910	0.886	plasma	up	(Chen et al., 2020)
lncRNA MALAT1	190/190	0.823	0.755	plasma	up	(Geng et al., 2019)
lncRNA MALAT1/miR-125a	196/196	0.931	0.678	plasma	up	(Liu et al., 2020)
lncRNA ITSN1-2	309/300	0.777	0.654	plasma	up	(Zeng et al., 2019)
lnc-MEG3/miR-21 axis	219/219	0.934	0.669	plasma	up	(Na et al., 2020)
lncRNA ANRIL	126/125	0.843	0.785	plasma	up	(Gui et al., 2019)
lncRNA	Sepsis patients	Diagnosis value of organ dysfunctions (AUC)	Prognostic value of mortality (AUC)	sample	level	Ref
		Lung
lncRNA MALAT1	152	0.674	0.651	plasma	up	(Huang and Zhao, 2019)
Lnc-THRIL	109	0.706	0.780	plasma	up	(Wang et al., 2019)
		Kidney
lncRNA TCONS_00016233	192	0.894	-	plasma	up	(Zhang et al., 2020)